Literature DB >> 8100774

The invasin protein of Yersinia spp. provides co-stimulatory activity to human T cells through interaction with beta 1 integrins.

S J Brett1, A V Mazurov, I G Charles, J P Tite.   

Abstract

The invasin proteins of Yersinia spp. are outer membrane proteins which are involved in the penetration of these bacteria into mammalian cells (Cell 1990. 60: 861). Invasin binds to several different beta 1 integrins with extremely high affinity, the integrin-binding domain of invasin has been mapped to the C-terminal 192 amino-acids of the molecule (J. Biol. Chem. 1991. 266:24367). Expression of this fragment alone on the cell surface of non-invasive bacteria is enough to confer the invasive phenotype on these strains (EMBO J. 1990. 9: 1979). Here we show that the carboxy-terminal 192 amino acids of invasin expressed as a fusion protein with the maltose binding protein of E. coli is capable of delivering co-stimulatory signals to human T cells through the beta 1 integrins. Co-stimulation was assayed by the ability of invasin to augment the response of highly purified CD4+ and CD8+ T cells to co-immobilized anti-CD3 antibody. Antibody blocking studies indicated that the co-stimulation was mediated through beta 1 integrins. The proliferation induced by co-stimulation of CD4+ T cells was accompanied by the synthesis of the cytokines tumor necrosis factor-alpha and interferon-gamma, whereas the activation of CD8+ T cells led to the generation of cytotoxic effectors. The region of the invasin molecule involved in T cell activation was further mapped using synthetic peptides. A region of the invasin molecule containing the residues TAKSKKFPSY could substitute for invasin in T cell activation. The co-stimulation by peptide could also be inhibited by anti-integrin antibodies. The observation that an outer membrane protein of a bacterium which is associated with reactive arthritis and other autoimmune spondyloarthropathies can act as a T cell co-stimulus may have implications for the etiology of these diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100774     DOI: 10.1002/eji.1830230732

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Binding of intimin from enteropathogenic Escherichia coli to lymphocytes and its functional consequences.

Authors:  Nathalie S Gonçalves; Christine Hale; Gordon Dougan; Gad Frankel; Thomas T MacDonald
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.

Authors:  A T Florence
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

3.  Invasin of Yersinia pseudotuberculosis activates human peripheral B cells.

Authors:  E Lundgren; N Carballeira; R Vazquez; E Dubinina; H Bränden; H Persson; H Wolf-Watz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

4.  Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles.

Authors:  N Hussain; A T Florence
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 5.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

6.  Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines.

Authors:  I B Autenrieth; V Kempf; T Sprinz; S Preger; A Schnell
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

7.  Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease.

Authors:  Vera Sobek; Nico Birkner; Ingrid Falk; Andreas Würch; Carsten J Kirschning; Hermann Wagner; Reinhard Wallich; Marinus C Lamers; Markus M Simon
Journal:  Arthritis Res Ther       Date:  2004-07-19       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.